668P Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223

Autor:	A. Zlotta, Robert J. Hamilton, Srikala S. Sridhar, Padraig Warde, Husam Alqaisi, Charles Catton, Nazanin Fallah-Rad, Adrian G. Sacher, Aaron R. Hansen, Neil Fleshner, Di Maria Jiang, Esmail Mutahar Al-Ezzi, Marco A. J. Iafolla
Rok vydání:	2020
Předmět:	Radium-223 Oncology medicine.medical_specialty Prostate cancer business.industry Internal medicine medicine Hematology Castration resistant business medicine.disease medicine.drug
Zdroj:	Annals of Oncology. 31:S537-S538
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e7bc426fc1776c8c8083f04711314162 https://doi.org/10.1016/j.annonc.2020.08.927 Zobrazit plný text záznamu